BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15312276)

  • 21. Psychiatric care in Parkinson's disease.
    Quelhas R
    J Psychiatr Pract; 2013 Mar; 19(2):118-41. PubMed ID: 23507813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosis in Parkinson's disease: how should we treat it?
    Shotbolt P; Samuel M; Anthony D
    Expert Rev Neurother; 2006 Sep; 6(9):1243-6. PubMed ID: 17009911
    [No Abstract]   [Full Text] [Related]  

  • 24. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep disorders in Parkinson's disease.
    Abdelgabar A; Sharma J
    Int J Clin Pract; 2003 Nov; 57(9):781-7. PubMed ID: 14686569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
    Visanji NP; Gomez-Ramirez J; Johnston TH; Pires D; Voon V; Brotchie JM; Fox SH
    Mov Disord; 2006 Nov; 21(11):1879-91. PubMed ID: 16960862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical management of advanced Parkinson's disease.
    Goudreau JL
    Clin Geriatr Med; 2006 Nov; 22(4):753-72, v. PubMed ID: 17000334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hallucinations and psychosis in Parkinson's disease.
    Eng ML; Welty TE
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):316-30. PubMed ID: 20869621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of early Parkinson's disease. Part 2.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):206-15. PubMed ID: 19176961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease: drug-induced psychiatric states.
    Factor SA; Molho ES; Podskalny GD; Brown D
    Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Other symptoms of advanced stage Parkinson's disease].
    Pollak P; Tranchant C
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():165-73. PubMed ID: 10916048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiety disorders in Parkinson's disease.
    Richard IH
    Adv Neurol; 2005; 96():42-55. PubMed ID: 16383211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse events from the treatment of Parkinson's disease.
    Chou KL
    Neurol Clin; 2008 Aug; 26(3 Suppl):S65-83, vi. PubMed ID: 18774443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropsychiatry of Parkinson's disease.
    Lauterbach EC
    Minerva Med; 2005 Jun; 96(3):155-73. PubMed ID: 16175159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Understanding of Psychosis in Parkinson's Disease.
    Ojo OO; Fernandez HH
    Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.